APA (7th ed.) Citation

Ran, X., Wang, Y., Li, S., & Dai, C. Effects of Bifidobacterium and rosuvastatin on metabolic-associated fatty liver disease via the gut–liver axis. BMC.

Chicago Style (17th ed.) Citation

Ran, Xue, Ying-jie Wang, Shi-gang Li, and Chi-bing Dai. Effects of Bifidobacterium and Rosuvastatin on Metabolic-associated Fatty Liver Disease via the Gut–liver Axis. BMC.

MLA (9th ed.) Citation

Ran, Xue, et al. Effects of Bifidobacterium and Rosuvastatin on Metabolic-associated Fatty Liver Disease via the Gut–liver Axis. BMC.